Stay updated on Brilacidin Efficacy in COVID-19 Hospitalized Clinical Trial

Sign up to get notified when there's something new on the Brilacidin Efficacy in COVID-19 Hospitalized Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brilacidin Efficacy in COVID-19 Hospitalized Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T23:19:57.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the study results related to the efficacy and safety of Brilacidin in hospitalized participants with COVID-19.
    Difference
    0.1%
    Check dated 2024-06-06T14:29:28.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The webpage now indicates that the results for the study on Brilacidin IV infusion in hospitalized COVID-19 patients have been posted with quality control comments as of 2022-08-22. This update includes detailed participant flow, baseline characteristics, and outcome measures for the different treatment arms.
    Difference
    73%
    Check dated 2024-05-22T21:34:35.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2024-04-30T22:51:00.000Z thumbnail image

Stay in the know with updates to Brilacidin Efficacy in COVID-19 Hospitalized Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brilacidin Efficacy in COVID-19 Hospitalized Clinical Trial page.